Alkynyl Benzoxazines and Dihydroquinazolines as Cysteine Targeting Covalent Warheads and Their Application in Identification of Selective Irreversible Kinase Inhibitors

Journal: Journal of the American Chemical Society

Published: 2020-06-02

DOI: 10.1021/jacs.9b13391

Affiliations: 9

Authors: 15

Go to article
Institutions Share
AstraZeneca plc, United Kingdom (UK) 0.67
Department of Chemistry, University of Cambridge, United Kingdom (UK) 0.09
AstraZeneca Waltham, United States of America (USA) 0.07
Cambridge Centre for Proteomics (CPP), University of Cambridge, United Kingdom (UK) 0.07
Northern Institute for Cancer Research (NICR), Newcastle University, United Kingdom (UK) 0.03
School of Chemistry, Newcastle University, United Kingdom (UK) 0.03
Institute of Molecular Medicine (IMM), Portugal 0.02
Faculdade de Medicina da Universidade de Lisboa (FMUL), ULISBOA, Portugal 0.02

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER